STAAR Surgical Co Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
STAAR Surgical Co (STAA) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $163.00 thousand for the 12-month period ending 2024-12-27, per its 10-K filed 2026-03-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2026-03-03
- STAAR Surgical Co effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2024 was $163.00K, a 21.64% increase from fiscal 2023.
- STAAR Surgical Co effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2023 was $134.00K, a 24.07% increase from fiscal 2022.
- STAAR Surgical Co effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2022 was $108.00K.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month |
|---|---|
| 2024-12-27 | $163.00K 10-K · filed 2026-03-03 |
| 2023-12-29 | $134.00K 10-K · filed 2026-03-03 |
| 2022-12-30 | $108.00K 10-K · filed 2025-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |